CSBC Corporation (TPE:2208)

Market Cap	20.97B
Revenue (ttm)	14.66B
Net Income (ttm)	-3.27B
Shares Out	1.27B
EPS (ttm)	-2.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,794,839
Average Volume	2,374,494
Open	16.45
Previous Close	16.45
Day's Range	16.10 - 16.45
52-Week Range	14.20 - 19.55
Beta	0.84
RSI	41.70
Earnings Date	Aug 19, 2025

About CTI BioPharma

CSBC Corporation engages in building, manufacture, and repair of various ships and offshore engineering in Taiwan, Europe, rest of Asia, Africa, and the United States. It offers bulk, cement, and product carriers; and container ships, reefer vessels, tankers, tug boats, and naval ships, as well as oil drilling rigs. The company also provides ship repair services; and offshore engineering services; offshore wind steel structures, such as pin piles, transition piece, pile grippers, and ship unloaders, as well as level luffing cranes. In addition,...

• Industry: Aerospace & Defense
• Sector: Industrials
• Founded: 1973
• Employees: 2,785
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 2208

Financial Performance

In 2024, CSBC Corporation's revenue was 14.49 billion, a decrease of -32.51% compared to the previous year's 21.48 billion. Losses were -2.78 billion, -31.03% less than in 2023.